The study results, published Wednesday in the New England Journal of Medicine, are the latest development in a highly charged medical and political issue — the efficacy of hydroxychloroquine in combating covid-19, the disease caused by the coronavirus.
President Trump has repeatedly touted the drug and recently said he took it for several days. The study, by researchers at the University of Minnesota Medical School, was a randomized placebo-controlled trial and was double-blinded — meaning neither the participants nor the researchers knew what the participants received. Such a study is considered the gold standard for clinical trials. |
No comments:
Post a Comment